Deerfield Management Company as of March 31, 2020
Portfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 90 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adapthealth Corp -a (AHCO) | 8.7 | $275M | 17M | 16.00 | |
| Mylan Nv | 5.7 | $181M | 12M | 14.91 | |
| Horizon Therapeutics | 5.5 | $174M | 5.9M | 29.62 | |
| Horizon Pharma Plc convertible security | 5.4 | $169M | 145M | 1.16 | |
| Nevro Corp note 1.750% 6/0 | 4.2 | $134M | 116M | 1.16 | |
| Dfp Healthcare Acquisitns Co unit 03/31/2025 | 3.3 | $103M | 11M | 9.85 | |
| Nuvasive Inc note 2.250% 3/1 | 2.8 | $89M | 85M | 1.04 | |
| Centene Corporation (CNC) | 2.4 | $75M | 1.3M | 59.41 | |
| Orchard Therapeutics Plc ads | 2.1 | $67M | 8.9M | 7.53 | |
| Homology Medicines | 2.0 | $63M | 4.0M | 15.54 | |
| Dexcom Inc convertible security | 1.9 | $59M | 34M | 1.73 | |
| Schrodinger (SDGR) | 1.8 | $58M | 1.3M | 43.12 | |
| Brookdale Senior Living (BKD) | 1.8 | $57M | 18M | 3.12 | |
| Immunomedics | 1.8 | $55M | 4.1M | 13.48 | |
| Abiomed | 1.7 | $55M | 376k | 145.16 | |
| Pacira Pharmaceuticals (PCRX) | 1.7 | $55M | 1.6M | 33.53 | |
| Insmed Inc convertible security | 1.6 | $51M | 61M | 0.83 | |
| Arvinas Ord (ARVN) | 1.6 | $49M | 1.2M | 40.30 | |
| Mirum Pharmaceuticals (MIRM) | 1.5 | $48M | 3.4M | 14.00 | |
| Intercept Pharmas conv | 1.5 | $47M | 58M | 0.81 | |
| Rhythm Pharmaceuticals (RYTM) | 1.5 | $46M | 3.0M | 15.22 | |
| Axonics Modulation Technolog (AXNX) | 1.4 | $46M | 1.8M | 25.41 | |
| Clovis Oncology Inc note 2.500% 9/1 | 1.4 | $44M | 49M | 0.89 | |
| Silk Road Medical Inc Common (SILK) | 1.3 | $42M | 1.3M | 31.48 | |
| Alector (ALEC) | 1.3 | $42M | 1.7M | 24.13 | |
| Vericel (VCEL) | 1.3 | $41M | 4.4M | 9.17 | |
| Revolution Medicines (RVMD) | 1.2 | $39M | 1.8M | 21.91 | |
| Natera (NTRA) | 1.2 | $39M | 1.3M | 29.86 | |
| Fate Therapeutics (FATE) | 1.1 | $36M | 1.6M | 22.21 | |
| Aerie Pharmaceuticals | 1.1 | $34M | 2.5M | 13.50 | |
| Intersect Ent | 1.0 | $33M | 2.8M | 11.85 | |
| Acceleron Pharma | 1.0 | $31M | 343k | 89.87 | |
| Amicus Therapeutics (FOLD) | 1.0 | $30M | 3.3M | 9.24 | |
| Constellation Pharmceticls I | 1.0 | $30M | 954k | 31.43 | |
| Ptc Therapeutics Inc conv bd us | 0.9 | $27M | 25M | 1.08 | |
| Blueprint Medicines (BPMC) | 0.8 | $27M | 458k | 58.48 | |
| Tandem Diabetes Care (TNDM) | 0.8 | $27M | 413k | 64.35 | |
| Reata Pharmaceuticals Inc Cl A | 0.8 | $27M | 184k | 144.34 | |
| Deciphera Pharmaceuticals (DCPH) | 0.8 | $24M | 590k | 41.17 | |
| McKesson Corporation (MCK) | 0.8 | $24M | 175k | 135.26 | |
| BioDelivery Sciences International | 0.7 | $23M | 6.2M | 3.79 | |
| Dex (DXCM) | 0.7 | $23M | 87k | 269.26 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $23M | 1.7M | 13.95 | |
| Molina Healthcare (MOH) | 0.7 | $23M | 165k | 139.71 | |
| Sarepta Therapeutics (SRPT) | 0.7 | $23M | 235k | 97.82 | |
| Editas Medicine (EDIT) | 0.7 | $23M | 1.2M | 19.83 | |
| Springworks Therapeutics (SWTX) | 0.7 | $21M | 788k | 27.00 | |
| Dbv Technologies S A (DBVT) | 0.6 | $20M | 5.2M | 3.92 | |
| Adverum Biotechnologies | 0.6 | $20M | 2.1M | 9.77 | |
| Argenx Se (ARGX) | 0.6 | $20M | 152k | 131.73 | |
| Jazz Investments I Ltd. conv | 0.6 | $19M | 20M | 0.96 | |
| Pacira Pharmaceuticals Inc convertible security | 0.6 | $19M | 20M | 0.95 | |
| Mirati Therapeutics | 0.6 | $19M | 242k | 76.87 | |
| Turning Point Therapeutics I | 0.6 | $19M | 413k | 44.66 | |
| Ardelyx (ARDX) | 0.6 | $18M | 3.1M | 5.68 | |
| Avrobio Ord (AVRO) | 0.6 | $18M | 1.1M | 15.56 | |
| Frequency Therapeutics | 0.5 | $17M | 946k | 17.81 | |
| Myokardia | 0.5 | $16M | 346k | 46.88 | |
| Glaukos (GKOS) | 0.5 | $16M | 518k | 30.86 | |
| Select Medical Holdings Corporation (SEM) | 0.5 | $16M | 1.1M | 15.00 | |
| Forty Seven | 0.5 | $15M | 155k | 95.42 | |
| Universal Health Services (UHS) | 0.4 | $14M | 139k | 99.08 | |
| Black Diamond Therapeutics (BDTX) | 0.4 | $13M | 536k | 24.95 | |
| Passage Bio (PASG) | 0.3 | $11M | 670k | 15.75 | |
| Vapotherm | 0.3 | $11M | 557k | 18.83 | |
| Cerus Corporation (CERS) | 0.3 | $10M | 2.2M | 4.65 | |
| Artara Therapeutics | 0.3 | $10M | 433k | 23.00 | |
| Axogen (AXGN) | 0.3 | $9.8M | 938k | 10.40 | |
| Cabaletta Bio (CABA) | 0.3 | $9.4M | 1.3M | 7.30 | |
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $9.3M | 4.7M | 2.00 | |
| Applied Therapeutics (APLT) | 0.3 | $9.1M | 278k | 32.69 | |
| Sientra | 0.3 | $8.4M | 4.2M | 1.99 | |
| Puma Biotechnology (PBYI) | 0.3 | $8.1M | 963k | 8.44 | |
| Imara | 0.3 | $8.0M | 500k | 16.03 | |
| Mallinckrodt Pub | 0.3 | $8.0M | 4.0M | 1.98 | |
| Lumos Pharma (LUMO) | 0.3 | $8.0M | 936k | 8.50 | |
| Iveric Bio | 0.2 | $7.8M | 2.3M | 3.44 | |
| Syros Pharmaceuticals | 0.2 | $7.5M | 1.3M | 5.93 | |
| Xeris Pharmaceuticals | 0.2 | $6.7M | 3.4M | 1.95 | |
| Itamar Med | 0.2 | $5.9M | 499k | 11.78 | |
| Neuronetics (STIM) | 0.1 | $3.0M | 1.6M | 1.89 | |
| Intercept Pharmaceuticals In Note 2.000 5/1 bnd | 0.1 | $3.0M | 3.5M | 0.85 | |
| Change Healthcare | 0.1 | $2.1M | 215k | 9.99 | |
| Harpoon Therapeutics | 0.1 | $1.9M | 168k | 11.58 | |
| Oxford Immunotec Global | 0.0 | $1.4M | 154k | 9.26 | |
| Millendo Therapeutics | 0.0 | $892k | 169k | 5.28 | |
| Endologix | 0.0 | $656k | 950k | 0.69 | |
| Synlogic | 0.0 | $654k | 380k | 1.72 | |
| Neos Therapeutics | 0.0 | $241k | 321k | 0.75 | |
| Kempharm | 0.0 | $94k | 419k | 0.22 |
